SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 119 filers reported holding SUTRO BIOPHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $982,284 | -13.0% | 283,079 | +16.6% | 0.31% | -1.0% |
| Q2 2023 | $1,128,922 | +188.5% | 242,779 | +186.6% | 0.31% | +164.1% |
| Q1 2023 | $391,314 | -13.2% | 84,700 | +4.3% | 0.12% | -3.3% |
| Q3 2022 | $451,000 | +2.3% | 81,200 | -4.1% | 0.12% | +0.8% |
| Q2 2022 | $441,000 | -36.6% | 84,700 | 0.0% | 0.12% | -33.7% |
| Q1 2022 | $696,000 | +3.9% | 84,700 | +88.2% | 0.18% | +7.7% |
| Q4 2021 | $670,000 | -58.3% | 45,000 | -47.1% | 0.17% | -60.6% |
| Q3 2021 | $1,606,000 | +1.6% | 85,000 | 0.0% | 0.43% | +29.1% |
| Q2 2021 | $1,580,000 | -18.3% | 85,000 | 0.0% | 0.33% | -28.1% |
| Q1 2021 | $1,935,000 | +4.9% | 85,000 | 0.0% | 0.46% | -16.4% |
| Q4 2020 | $1,845,000 | +54.4% | 85,000 | -28.5% | 0.55% | +41.5% |
| Q3 2020 | $1,195,000 | +44.7% | 118,940 | +11.7% | 0.39% | +63.0% |
| Q2 2020 | $826,000 | +102.5% | 106,444 | +166.1% | 0.24% | +40.0% |
| Q1 2020 | $408,000 | -7.3% | 40,000 | 0.0% | 0.17% | +12.6% |
| Q4 2019 | $440,000 | +20.9% | 40,000 | 0.0% | 0.15% | +10.2% |
| Q3 2019 | $364,000 | +1.7% | 40,000 | +27.0% | 0.14% | +1.5% |
| Q2 2019 | $358,000 | -0.3% | 31,494 | 0.0% | 0.14% | -12.9% |
| Q1 2019 | $359,000 | +26.4% | 31,494 | 0.0% | 0.16% | +9.9% |
| Q4 2018 | $284,000 | -31.1% | 31,494 | +14.5% | 0.14% | -16.6% |
| Q3 2018 | $412,000 | – | 27,494 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,675,579 | $5,814,259 | 1.78% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,883,693 | $20,416,415 | 1.10% |
| Kynam Capital Management, LP | 1,552,675 | $5,387,782 | 0.88% |
| Parkman Healthcare Partners LLC | 1,182,168 | $4,102,123 | 0.75% |
| Rubric Capital Management LP | 3,344,810 | $11,606,491 | 0.44% |
| BVF INC/IL | 3,347,946 | $11,617,373 | 0.31% |
| DAFNA Capital Management LLC | 283,079 | $982,284 | 0.31% |
| SECTORAL ASSET MANAGEMENT INC | 432,339 | $1,500,216 | 0.29% |
| Eversept Partners, LP | 769,638 | $2,670,644 | 0.23% |
| Frazier Life Sciences Management, L.P. | 780,000 | $2,706,600 | 0.18% |